Single-cell Omics Market Size

  • Report ID: 5060
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Single-cell Omics Market Size

Single-cell Omics Market size was valued at USD 4.44 billion in 2024 and is set to exceed USD 59.52 billion by 2037, expanding at over 22.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of single-cell omics is evaluated at USD 5.22 billion.  

Advancement in the studies of RNA sequencing is a major driver for the growth of the single-cell omics market. Since RNA sequencing provides a comprehensive snapshot of gene expression profiles in cells. By studying gene expression patterns at the single-cell level, researchers can identify and characterize distinct cell populations and subtypes within a tissue or organism. This has opened up new avenues for single-cell omics development.

Besides this, the rising investment in cell sequencing is also expected to augment the single-cell omics market growth. The National Institutes of Health (NIH) recently granted Texas A&M University System a USD 1.19 million grant for a collaboration between multiple disciplines to explore the deep links between genomes, nutrition, and health. The investment in cell sequencing is driven by the growing demand for single-cell omics research. Moreover, higher investment enables the development of innovative approaches for disease diagnosis, and therapeutic development.


Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5060
  • Published Date: Nov 15, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of single-cell omics is evaluated at USD 5.22 billion.

The single-cell omics market size was valued at USD 4.44 billion in 2024 and is set to exceed USD 59.52 billion by 2037, expanding at over 22.1% CAGR during the forecast period i.e., between 2025-2037. Increasing incidences of cancer, rising investment in cell therapy, and technological advancement of single-cell techniques will drive the market growth.

North America industry is set to hold largest revenue share of 40% by 2037, impelled by rising investment in advanced healthcare technologies.

The major players in the market are Ultima Genomics, Inc., 10x Genomics, Inc., Becton, Dickinson and Company (BD), CELLENION, PerkinElmer Inc., ANGLE plc, Illumina, Inc., Bio-Rad Laboratories, Inc., Mission Bio, Inc., Standard BioTools Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample